Skip to content

Comparison of Total Intravenous Anesthesia versus Inhalation Anesthesia on Postoperative Neurological Recovery in Patients Undergoing Endovascular Therapy for Acute Anterior Circulation Ischemic Stroke: A Multicenter, Double-Blind, Randomized Controlled Trial

Comparison of Total Intravenous Anesthesia versus Inhalation Anesthesia on Postoperative Neurological Recovery in Patients Undergoing Endovascular Therapy for Acute Anterior Circulation Ischemic Stroke: A Multicenter, Double-Blind, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114255
Enrollment
Unknown
Registered
2025-12-09
Start date
2025-12-25
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Inhalational Anesthesia Group:Sevoflurane-based Inhalational Anesthesia
Total intravenous anesthesia Group:Propofol-based Intravenous Anesthesia

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years and <= 90 years (inclusive) ; 2. Occlusion of large vessels in the anterior cerebral circulation (internal carotid artery, or M1/M2 segments of the middle cerebral artery) confirmed by computed tomography angiography (CTA) or magnetic resonance angiography (MRA) ; 3. Ability to live independently before stroke, with an estimated pre-stroke modified Rankin Scale (mRS) score of 0–2 ; 4. Provision of informed consent by the patient and their legal guardian (if applicable)..

Exclusion criteria

Exclusion criteria: 1. Pre-existing vascular diseases that preclude the current endovascular treatment, such as aortic dissection, aneurysm, and other analogous conditions; 2. National Institutes of Health Stroke Scale (NIHSS) score 30; 3.Patients with ASPECTS<=6; 4. Patients with pre-existing intracranial hemorrhage; 5. Pre-existing neurological or psychiatric disorders that may interfere with the assessment of postoperative neurological function; 6. Patients with a history of allergy to contrast media or anesthetics; 7. Patients with comorbid infective endocarditis; 8. Patients with intracranial space-occupying lesions or tumors confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); 9. Patients concurrently participating in other clinical trials;

Design outcomes

Primary

MeasureTime frame
Proportion of patients with modified Rankin Scale score <= 2;

Secondary

MeasureTime frame
The ordinal scores on the modified Rankin Scale (mRS) ;National Institutes of Health Stroke Scale score;Score on the modified Thrombolysis in Cerebral Infarction Scale immediately after endovascular therapy;Global health status assessed by the Patient-Reported Outcomes Measurement Information System Global-10;Health-related quality of life assessed by the EuroQol-5 Dimensions questionnaire;Anxiety and depression symptoms ;All-cause mortality at 3 months post-operation;Major Vascular Events;Incidence of major in-hospital complications;Incidence of symptomatic intracranial hemorrhage within 48 hours post-operation;Rate of decompressive craniectomy performed;Duration of assisted ventilation;Total length of hospital stay;Length of stay in the Intensive Care Unit;All-cause mortality at 30 days post-operation;

Countries

China

Contacts

Public ContactHong Li

The Second Affiliated Hospital of Army Medical University

lh78533@163.com+86 136 0838 0123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026